On Wednesday, March 17th at Noon, the DC Chapter of the Technology Transfer Society is sponsoring a briefing on the U.S. Government Accountability Office’s efforts to expand Congress’s capabilities in science and technology (S&T) analysis and assessment. Since the demise of the Office of Technology Assessment in the 1990’s, Congress has lacked robust in-house analytical capability to effectively analyze new scientific and technological advances. Rapid developments in S&T are transforming multiple sectors of society. Like all technological change, these developments bring both opportunities and the potential for unintended consequences. The ability of Congress to understand, evaluate, and prepare for such changes is critical for the United States to remain secure, innovative, and globally competitive.
In January 2019, GAO created the Science, Technology Assessment, and Analytics (STAA) team to build on and expand its decades-long work providing Congress with S&T analysis. STAA is a large interdisciplinary technical team that advises Congress, generates policy options, and informs legislation on topics in the computational sciences (such as artificial intelligence and advanced data analytics), physical sciences (such as sustainable chemistry and nuclear waste management), life sciences (such as epidemiology of emerging infectious diseases and biosurety of Select Agents), and engineering (such as IoT, 3D printing, and hypersonic systems).
Dr. Tim Persons and Dr. Karen Howard of GAO will discuss STAA’s history, organization, and its technology assessment portfolio.
Interested persons are invited to submit comments to the Federal Register on or before 11:59 p.m. (ET) on March 15, 2019.
The Government anticipates hosting a conference in June/July 2019 to allow for additional engagement. The results of the conference discussion, in addition to the written responses to this RFI, will be used to determine next steps in addressing federal efforts in interoperability of data, platforms, and medical devices. This RFI is solely issued to engage with interested parties to inform the Government on developing a strategy for medical device, data, and platform interoperability. The Government will not reimburse costs associated with participating in the conference. The Government may contact respondents regarding their submissions, such as to ask questions, to learn more, or to notify them of further developments related to the effort.
Several media outlets are reporting that the Trump Administration will issue an executive order on artificial intelligence strategy as soon as today — Monday, February 11th. According to the New York Times, the order does not set aside funds for A.I. research and development, and there are few details on how any new policies will be put into effect. More information on the new order will be posted as it becomes available.